QTc prolongation among hospitalized patients receiving methadone [9]

Archives of Internal Medicine

Volumn 166, Issue 20, 2006, Pages 2289-

  Schmittner, John ^b   Krantz, Mori J ^a  

^a DENVER HEALTH AND HOSPITAL AUTHORITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

METHADONE; OPIATE;

DRUG DOSE REGIMEN; FOOD AND DRUG ADMINISTRATION; HEALTH PROGRAM; HEART DISEASE; HOSPITAL PATIENT; HUMAN; LETTER; MEDICAL PRACTICE; PRIORITY JOURNAL; QT PROLONGATION;

EID: 33750980395     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.166.20.2289-b     Document Type: Letter

References (4)

1. Ehret GB, Voide C, Gex-Fabry M, et al. Drug-induced long QT syndrome in injection drug users receiving methadone: high frequency in hospitalized patients and risk factors. Arch Intern Med. 2006;166:1280-1287.
2. Krantz MJ, Kutinsky IB, Robertson AD, Mehler PS. Dose-related effects of methadone on QT prolongation in a series of patients with torsade de pointes. Pharmacotherapy. 2003;23:802-805.
3. Pearson EC, Woosley RL. QT prolongation and torsades de pointes among methadone users: reports to the FDA spontaneous reporting system. Pharmacoepidemiol Drug Saf. 2005;14:747-753.
4. Krantz MJ, Mehler PS. Treating opioid dependence: growing implications for primary care. Arch Intern Med. 2004;164:277-288.